Gaal Lubor 4
4 · Timber Pharmaceuticals, Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
Gaal Lubor
Director
Transactions
- Award
Common Stock, par value $0.001 per share
2023-04-15+4,100→ 6,100 total - Award
Stock Option (right to buy)
2023-04-15+4,100→ 4,100 totalExercise: $1.66Exp: 2032-04-14→ Common Stock (4,100 underlying)
Footnotes (2)
- [F1]On April 15, 2023, the Reporting Person was granted 4,100 restricted stock units, which will be settled in shares of common stock, par value $0.001. The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.
- [F2]25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.